Market capitalization is the total value the stock market puts on a company: its share price multiplied by the number of shares outstanding. Each point here is the share count reported in a filing multiplied by the closing price on that filing date, adjusted for later stock splits, so the history moves when a new filing arrives rather than with each day's trading. A larger market cap means investors collectively value the company more highly; by itself it says nothing about profit or debt. Annual points keep the latest observation in each calendar year.
Verastem, Inc. market cap for the quarter ending 2026-08-03 was $516.21M, a 48.98% increase year-over-year.
Verastem, Inc. market cap for the quarter ending 2026-06-30 was $345.64M, a 35.38% increase year-over-year.
Verastem, Inc. market cap for the quarter ending 2026-05-04 was $521.09M, a 30.08% increase year-over-year.
Verastem, Inc. market cap for the quarter ending 2026-03-31 was $464.69M, a 49.67% increase year-over-year.
Verastem, Inc. market cap for fiscal 2026 was $516.21M.
Verastem, Inc. market cap for fiscal 2025 was $600.93M, a 159.54% increase from fiscal 2024.
Verastem, Inc. market cap for fiscal 2024 was $231.53M, a 12.51% increase from fiscal 2023.
Verastem, Inc. market cap for fiscal 2023 was $205.79M, a 156.54% increase from fiscal 2022.